Axsome Therapeutics Inc (AXSM)
99.95
-0.54
(-0.54%)
USD |
NASDAQ |
Dec 04, 14:10
Axsome Therapeutics Market Cap: 4.844B for Dec. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| December 03, 2024 | 4.870B |
| December 02, 2024 | 4.802B |
| November 29, 2024 | 4.760B |
| November 27, 2024 | 4.829B |
| November 26, 2024 | 4.702B |
| November 25, 2024 | 4.725B |
| November 22, 2024 | 4.782B |
| November 21, 2024 | 4.759B |
| November 20, 2024 | 4.585B |
| November 19, 2024 | 4.626B |
| November 18, 2024 | 4.480B |
| November 15, 2024 | 4.515B |
| November 14, 2024 | 4.719B |
| November 13, 2024 | 4.741B |
| November 12, 2024 | 4.822B |
| November 11, 2024 | 4.409B |
| November 08, 2024 | 4.365B |
| November 07, 2024 | 4.396B |
| November 06, 2024 | 4.409B |
| November 05, 2024 | 4.325B |
| November 04, 2024 | 4.226B |
| November 01, 2024 | 4.303B |
| October 31, 2024 | 4.312B |
| October 30, 2024 | 4.333B |
| October 29, 2024 | 4.376B |
| Date | Value |
|---|---|
| October 28, 2024 | 4.365B |
| October 25, 2024 | 4.353B |
| October 24, 2024 | 4.303B |
| October 23, 2024 | 4.472B |
| October 22, 2024 | 4.475B |
| October 21, 2024 | 4.432B |
| October 18, 2024 | 4.522B |
| October 17, 2024 | 4.522B |
| October 16, 2024 | 4.358B |
| October 15, 2024 | 4.186B |
| October 14, 2024 | 4.137B |
| October 11, 2024 | 4.241B |
| October 10, 2024 | 4.024B |
| October 09, 2024 | 4.046B |
| October 08, 2024 | 4.108B |
| October 07, 2024 | 4.076B |
| October 04, 2024 | 4.194B |
| October 03, 2024 | 4.416B |
| October 02, 2024 | 4.516B |
| October 01, 2024 | 4.384B |
| September 30, 2024 | 4.353B |
| September 27, 2024 | 4.303B |
| September 26, 2024 | 4.303B |
| September 25, 2024 | 4.316B |
| September 24, 2024 | 4.383B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
750.25M
Minimum
Aug 19 2021
4.870B
Maximum
Dec 03 2024
2.739B
Average
2.840B
Median
Aug 24 2022
Market Cap Benchmarks
| Repligen Corp | 8.291B |
| Pfizer Inc | 142.98B |
| NovaBay Pharmaceuticals Inc | 2.931M |
| Palatin Technologies Inc | 19.26M |
| iBio Inc | 24.15M |
Market Cap Related Metrics
| PS Ratio | 14.06 |
| PEG Ratio | -0.3467 |
| Price to Book Value | 52.14 |
| Price | 99.95 |
| Earnings Yield | -6.53% |
| PEGY Ratio | -0.3467 |